NeuroSense Therapeutics Ltd.

The current price of NRSN is 1.34 USD — it has decreased by 1.47% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NeuroSense Therapeutics Ltd. stocks are traded under the ticker NRSN.

NeuroSense Therapeutics Ltd. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.

NRSN stock is 15.38% volatile and has beta coefficient of 4.18. Check out the list of the most volatile stocks — is NeuroSense Therapeutics Ltd. there?

NRSN earnings for the last quarter are 0.05 USD per share, whereas the estimation was −0.26 USD resulting in a 117.31% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about NeuroSense Therapeutics Ltd. earnings.

Yes, you can track NeuroSense Therapeutics Ltd. financials in yearly and quarterly reports right on TradingView.

NRSN net income for the last quarter is ‪−2.95 M‬ USD, while the quarter before that showed ‪784.00 K‬ USD of net income which accounts for −476.28% change. Track more NeuroSense Therapeutics Ltd. financial stats to get the full picture.

Today NeuroSense Therapeutics Ltd. has the market capitalization of ‪23.23 M‬, it has decreased by 18.18% over the last week.

No, NRSN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, NRSN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NeuroSense Therapeutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.

NRSN reached its all-time high on Mar 21, 2022 with the price of 8.18 USD, and its all-time low was 0.40 USD and was reached on Oct 24, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 18.00 employees. See our rating of the largest employees — is NeuroSense Therapeutics Ltd. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NeuroSense Therapeutics Ltd. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NeuroSense Therapeutics Ltd. stock shows the sell signal. See more of NeuroSense Therapeutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.